Mostrar el registro sencillo del ítem

dc.contributor.author
Manrique, Julieta Marina  
dc.contributor.author
Piatak, Michael  
dc.contributor.author
Lauer, William  
dc.contributor.author
Johnson, Welkin  
dc.contributor.author
Mansfield, Keith  
dc.contributor.author
Lifson, Jeffrey  
dc.contributor.author
Desrosier, Ronald  
dc.date.available
2015-12-28T20:04:26Z  
dc.date.issued
2013-07  
dc.identifier.citation
Manrique, Julieta Marina; Piatak, Michael; Lauer, William; Johnson, Welkin; Mansfield, Keith; et al.; Influence of mismatch of env sequences on vaccine protection by live attenuated simian immunodeficiency virus; American Society for Microbiology; Journal of Virology; 87; 13; 7-2013; 7246-7254  
dc.identifier.issn
0022-538X  
dc.identifier.uri
http://hdl.handle.net/11336/3260  
dc.description.abstract
Vaccine/challenge experiments that utilize live attenuated strains of simian immunodeficiency virus (SIV) in monkeys may be useful for elucidating what is needed from a vaccine in order to achieve protective immunity. Derivatives of SIVmac239 and SIVmac239Δnef were constructed in which env sequences were replaced with those of the heterologous strain E543; these were then used in vaccine/challenge experiments. When challenge occurred at 22 weeks, 10 of 12 monkeys exhibited apparent sterilizing immunity despite a mismatch of Env sequences, compared to 12 of 12 monkeys with apparent sterilizing immunity when challenge virus was matched in its Env sequence. However, when challenge occurred at 6 weeks, 6 of 6 SIV239Δnef-immunized monkeys became superinfected by challenge virus mismatched in its Env sequence (SIV239/EnvE543). These results contrast markedly not only with the results of the week 22 challenge but also with the sterilizing immunity observed in 5 of 5 SIV239Δnef-immunized rhesus monkeys challenged at 5 weeks with SIV239, i.e., with no mismatch of Env sequences. We conclude from these studies that a mismatch of Env sequences in the challenge virus can have a dramatic effect on the extent of apparent sterilizing immunity when challenge occurs relatively early, 5 to 6 weeks after the nef-deleted SIV administration. However, by 22 weeks, mismatch of Env sequences has little or no influence on the degree of protection against challenge virus. Our findings suggest that anti-Env immune responses are a key component of the protective immunity elicited by live attenuated, nef-deleted SIV.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
American Society for Microbiology  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Vaccine  
dc.subject
Simian Immunodeficiency Virus  
dc.subject.classification
Virología  
dc.subject.classification
Ciencias Biológicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.subject.classification
Farmacología y Farmacia  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Influence of mismatch of env sequences on vaccine protection by live attenuated simian immunodeficiency virus  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2016-03-30 10:35:44.97925-03  
dc.journal.volume
87  
dc.journal.number
13  
dc.journal.pagination
7246-7254  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Washington  
dc.description.fil
Fil: Manrique, Julieta Marina. Harvard Medical School; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Nacional Patagónico; Argentina  
dc.description.fil
Fil: Piatak, Michael. Frederick National Laboratory. AIDS and Cancer Virus Program; Estados Unidos  
dc.description.fil
Fil: Lauer, William. Harvard Medical School; Estados Unidos  
dc.description.fil
Fil: Johnson, Welkin. Harvard Medical School; Estados Unidos  
dc.description.fil
Fil: Mansfield, Keith. Harvard Medical School; Estados Unidos  
dc.description.fil
Fil: Lifson, Jeffrey. Frederick National Laboratory. AIDS and Cancer Virus Program; Estados Unidos  
dc.description.fil
Fil: Desrosier, Ronald. Harvard Medical School; Estados Unidos  
dc.journal.title
Journal of Virology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1128%2FJVI.00798-13  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://journals.asm.org/doi/10.1128/JVI.00798-13